Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics's proprietary exosome engineering platform

OXFORD, United Kingdom, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced the publication in Nature Communications of Evox-funded research

Related Keywords

United Kingdom ,Redmile ,Leicestershire ,Simon Conway Natalie ,Evox Therapeutics Ltd ,Therapeutics Ltd ,Nature Communications ,Antonin De Fougerolles ,Chief Executive Officer ,